REFRACTORY GLIOBLASTOMA
Clinical trials for REFRACTORY GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on recurrent brain tumors in early trial
Disease control OngoingThis early-stage study tests a new treatment for people with malignant glioma that has returned or not responded to standard therapy. Doctors take a patient's own immune cells (T cells), add a special gene to help them recognize and attack the tumor, and infuse them back. The mai…
Matched conditions: REFRACTORY GLIOBLASTOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Last-resort drug offered to brain cancer patients with no options left
Disease control NO_LONGER_AVAILABLEThis program provides gallium maltolate (GaM) to adults with glioblastoma that has come back or not responded to treatment, and who have run out of standard options. The goal is to offer a possible way to control the disease when nothing else is available. Participants must be 18…
Matched conditions: REFRACTORY GLIOBLASTOMA
Sponsor: Imaging Biometrics, LLC • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Engineered immune cells take on recurrent brain tumors in early trial
Disease control OngoingThis early-phase study tests a new treatment for glioblastoma, a serious brain cancer that has returned or not responded to standard therapy. The approach uses specially engineered immune cells (CAR T cells) designed to target and attack the tumor, combined with drugs that boost …
Matched conditions: REFRACTORY GLIOBLASTOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC